Steve Hoerter

(Mr. Steven Hoerter)

Currently holds positions in Ignyta Inc, Constellation Pharmaceuticals Inc and Deciphera Pharmaceuticals Inc

Positions
Position Company Period
Independent Director Ignyta Inc Dec. 8, 2016 -
Independent Director Constellation Pharmaceuticals Inc Sept. 4, 2018 -
President, Chief Executive Officer, Director Deciphera Pharmaceuticals Inc March 18, 2019 -
Chief Commercial Officer Agios Pharmaceuticals Inc Feb. 16, 2016 - March 15, 2019
Senior Vice President, Chief Commercial Officer Clovis Oncology Inc Aug. 29, 2011 - Jan. 25, 2016
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-12-14 2023-12-13
S Sale
30,664 -29.6%
15.37
471,217 USD 		30,664 -29.6% 15.37 471,217 USD
2023-10-31 2023-10-30
S Sale
21,573 -34.5%
12.02
259,256 USD 		21,573 -34.5% 12.02 259,256 USD
2023-02-16 2023-02-14
PS Planned sale
30,045 -80.0%
16.00
480,720 USD 		30,045 -80.0% 16.00 480,720 USD
2019-03-05 2019-03-04
S Sale
5,000 -31.4%
68.00
340,000 USD 		5,000 -31.4% 68.00 340,000 USD
2019-03-05 2019-03-01
S Sale
5,000 -31.4%
66.01
330,050 USD 		5,000 -31.4% 66.01 330,050 USD
2018-07-27 2018-07-25
PS Planned sale
2,050 -100.0%
84.58
173,389 USD 		2,050 -100.0% 84.58 173,389 USD
2018-06-26 2018-06-22
PS Planned sale
2,050 -100.0%
97.58
200,039 USD 		2,050 -100.0% 97.58 200,039 USD
2018-05-29 2018-05-23
PS Planned sale
2,050 -100.0%
85.76
175,808 USD 		2,050 -100.0% 85.76 175,808 USD
2018-04-25 2018-04-23
PS Planned sale
2,050 -100.0%
85.95
176,198 USD 		2,050 -100.0% 85.95 176,198 USD
2018-03-26 2018-03-22
PS Planned sale
2,050 -100.0%
84.65
173,533 USD 		2,050 -100.0% 84.65 173,533 USD
2018-02-26 2018-02-22
PS Planned sale
2,050 -100.0%
78.63
161,192 USD 		2,050 -100.0% 78.63 161,192 USD
2018-01-25 2018-01-23
PS Planned sale
25,000 -100.0%
74.83
1,870,750 USD 		25,000 -100.0% 74.83 1,870,750 USD